Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The 5-HT 2C receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity
Colin Harvey-Lewis, Zhaoxia Li, Guy A. Higgins, et al.
Neuropharmacology (2015) Vol. 101, pp. 237-245
Closed Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience
Justin C. Strickland, William W. Stoops, Matthew L. Banks, et al.
Journal of the Experimental Analysis of Behavior (2022) Vol. 117, Iss. 3, pp. 384-403
Open Access | Times Cited: 15
Pharmacological Modulation of 5-HT2C Receptor Activity Produces Bidirectional Changes in Locomotor Activity, Responding for a Conditioned Reinforcer, and Mesolimbic DA Release in C57BL/6 Mice
Caleb J. Browne, Ji X, Guy A. Higgins, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2178-2187
Open Access | Times Cited: 27
Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.
Gregory T. Collins, Charles P. France
Experimental and Clinical Psychopharmacology (2018) Vol. 26, Iss. 5, pp. 488-496
Open Access | Times Cited: 24
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D3 receptor ligands
Peng-Jen Chen, Michelle Taylor, Suzy A. Griffin, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 18, pp. 2690-2694
Closed Access | Times Cited: 24
Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
S. Stevens Negus, Matthew L. Banks
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1967-1973
Open Access | Times Cited: 23
Converging vulnerability factors for compulsive food and drug use
Katherine M. Serafine, Laura E. O’Dell, Eric P. Zorrilla
Neuropharmacology (2021) Vol. 196, pp. 108556-108556
Open Access | Times Cited: 19
Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats
Brenda M. Gannon, Agnieszka Sulima, Kenner C. Rice, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 364, Iss. 2, pp. 359-366
Open Access | Times Cited: 24
5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers
Caroline A. Arout, Ziva D. Cooper, Stephanie Collins Reed, et al.
Addiction Biology (2021) Vol. 26, Iss. 4
Open Access | Times Cited: 13
Characterization of the discriminative stimulus effects of lorcaserin in rats
Katherine M. Serafine, Kenner C. Rice, Charles P. France
Journal of the Experimental Analysis of Behavior (2016) Vol. 106, Iss. 2, pp. 107-116
Open Access | Times Cited: 12
Dopamine Neurotransmission in the Ventral Tegmental Area Promotes Active Forgetting of Cocaine-Associated Memory
Fernando Castillo Díaz, Micaela A. Hernandez, Tomas Capellá, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 9, pp. 6206-6217
Open Access | Times Cited: 12
The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats
Gregory L. Powell, Mark D. Namba, Annika Vannan, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1076-1076
Open Access | Times Cited: 12
3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder
Michelle R. Doyle, Lindsey N. Peng, Jianjing Cao, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 384, Iss. 3, pp. 353-362
Open Access | Times Cited: 4
Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders
Maleesha Ubhayarathna, Christopher J. Langmead, Natalie Diepenhorst, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 22, pp. 4414-4429
Open Access | Times Cited: 4
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action
Myra Alayoubi, Brittany A. Henry, Catherine M. Cahill, et al.
Drugs (2024) Vol. 84, Iss. 11, pp. 1395-1417
Open Access | Times Cited: 1
Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate
Paul Fletcher, Fiona D. Zeeb, Caleb J. Browne, et al.
Psychopharmacology (2017) Vol. 234, Iss. 5, pp. 889-902
Closed Access | Times Cited: 12
The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge‐like ethanol drinking
Rayane I. Tabbara, Zhaoxia Li, Paul Fletcher, et al.
Addiction Biology (2021) Vol. 26, Iss. 5
Closed Access | Times Cited: 10
Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101
Guy A. Higgins, Leonardo B. Silenieks, Amy Patrick, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 5, pp. 1074-1084
Closed Access | Times Cited: 10
Effects of lorcaserin (Belviq®) on nicotine- and food-maintained responding in non-human primates
David S. Jacobs, Claire Barkin, Michelle R. Kohut, et al.
Drug and Alcohol Dependence (2017) Vol. 181, pp. 94-101
Open Access | Times Cited: 10
An up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity
Beverly G. Tchang, Brittany Abel, Christina Zecca, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 21, Iss. 1, pp. 21-28
Closed Access | Times Cited: 10
Innate cocaine-seeking vulnerability arising from loss of serotonin-mediated aversive effects of cocaine in rats
Ying S. Chao, Jeffrey Parrilla-Carrero, Maya Eid, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112404-112404
Open Access | Times Cited: 3
Ligand-directed serotonin 5-HT2C receptor desensitization and sensitization
Daniel E. Felsing, Clinton E. Canal, Raymond G. Booth
European Journal of Pharmacology (2019) Vol. 848, pp. 131-139
Open Access | Times Cited: 9
Lateral Habenula 5-HT2C Receptor Function Is Altered by Acute and Chronic Nicotine Exposures
Cristiano Bombardi, Francis Delicata, Claudio Tagliavia, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4775-4775
Open Access | Times Cited: 7
Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys
Lisa R. Gerak, Charles P. France
Drug and Alcohol Dependence (2021) Vol. 227, pp. 108991-108991
Open Access | Times Cited: 7
Acute and chronic interactive treatments of serotonin 5HT2C and dopamine D1 receptor systems for decreasing nicotine self-administration in female rats
Blair K. A. Willette, Anica Nangia, Sarah A. Howard, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 186, pp. 172766-172766
Open Access | Times Cited: 6
Serotonin neurobiology in cocaine use disorder
Kathryn A. Cunningham, Leonard L. Howell, Noelle C. Anastasio
Handbook of behavioral neuroscience (2020), pp. 745-802
Closed Access | Times Cited: 6

Scroll to top